John James Rickard Macleod: The Nobel Laureate Erased From His Own Discovery
In the autumn of 1921, when a nervous young surgeon named Frederick Banting froze in front of an audience at Yale, it was the physiologist who had lent him a lab, a student, and eight weeks of skepticism who stood up and finished the presentation for him. Two years later that physiologist, John James Rickard Macleod, shared the Nobel Prize for the discovery of insulin — and then spent the rest of his life watching the man he had rescued at the podium try to write him out of the story.
From a Manse in Perthshire to a Medical Degree
Macleod was born in 1876 near Dunkeld, Perthshire, the son of a minister; the family moved to Aberdeen when he was seven. He studied medicine at the University of Aberdeen, graduating with distinction in 1898, then chose the laboratory over the clinic — a year of biochemistry study in Leipzig on a traveling scholarship, followed by a doctorate in public health from Cambridge in 1902. He taught biochemistry at the London Hospital Medical School before crossing the Atlantic in 1903, aged twenty-six, to take a professorship in physiology at Western Reserve University in Cleveland, where he stayed fifteen years and built his reputation studying carbohydrate metabolism — the field that would define his career before he had any idea a Toronto surgeon would need him.
The Toronto Laboratory
In 1918 Macleod moved to the University of Toronto to direct its physiology laboratory. Two years later, in November 1920, a young surgeon with no research training, Frederick Banting, showed up with an idea: that ligating the pancreatic duct in dogs might isolate the internal secretion responsible for regulating blood sugar, without the digestive enzymes that had ruined earlier attempts to extract it. Macleod was doubtful — the idea wasn't new, and better-equipped scientists had already failed — but he gave Banting laboratory space, experimental animals, and the summer assistance of a talented undergraduate, Charles Best, before leaving for a trip to Scotland. When he returned to find Banting and Best had produced results, Macleod redirected the entire resources of his laboratory toward the problem: he taught the pair rigorous experimental controls, helped standardize how insulin's potency was measured, and brought in a skilled biochemist, James Collip, to purify the extract enough to use safely on human patients. The work that followed — moving from a treatment that nearly killed its first diabetic recipient to one that saved lives within months — depended on that combination of surgical audacity and physiological discipline.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Credit, Resentment, and the 1923 Nobel
The partnership soured almost immediately. Banting, prickly about status and furious that Macleod's polish and seniority let him command a room the way Banting himself could not, came to believe he was being crowded out of credit for his own idea. By the time the Nobel committee in Stockholm named the 1923 Physiology or Medicine laureates, it split the prize between Banting and Macleod — a decision Banting regarded as an insult, since it excluded Best. Banting immediately gave half his prize money to Best; Macleod, in turn, split his with Collip, an implicit acknowledgment of how many hands the discovery had actually required. Banting spent years afterward telling colleagues that Macleod had done nothing but "leave the keys to the laboratory," a line that stuck far longer than the truth behind it.
Return to Scotland and Later Years
Macleod left Toronto in 1928 to become Regius Professor of Physiology and Dean of the Medical Faculty at his alma mater, the University of Aberdeen, a post he held until his death. Even as arthritis increasingly disabled him, he stayed productive: he completed a lecture tour of the United States in 1933 and published a seventh edition of his textbook, Physiology and Biochemistry in Modern Medicine, in 1934. He died in Aberdeen in March 1935 at fifty-eight. Over his career he had published more than two hundred papers and eleven books, and he had been elected to the Royal Society, the Royal Society of Edinburgh, and the Royal Society of Canada, among other honors.
The Long Erasure and Its Reversal
After Banting's death in a 1941 plane crash, Charles Best kept the anti-Macleod narrative alive, and by the 1950s the public story of insulin had shrunk to two names, Banting and Best, with Macleod and Collip dropped almost entirely. It took the historian Michael Bliss's 1982 book The Discovery of Insulin, built from a close reading of the original laboratory notebooks, to restore the record: insulin, Bliss showed, was a collaborative process "initiated by Banting, directed by Macleod." The University of Aberdeen, which has pushed for decades to have Macleod's role recognized on a scale comparable to Alexander Fleming's for penicillin, still describes him as a figure "airbrushed from history." Formal recognition has followed, if slowly — his induction into the Canadian Medical Hall of Fame came in 2012, seventy-seven years after his death.
Why John Is Called a Genius
The word fits uneasily on Macleod, and the honest case for it is narrower than the Nobel medal suggests. He was not the one who conceived the pancreatic-duct-ligation idea — that was Banting's insight, born of a half-remembered medical-journal article. Macleod's genius, if the sources support the term at all, was the less romantic but equally rare capacity to recognize which raw, undisciplined result was worth the full weight of a serious laboratory: the judgment to redirect his program, the physiological expertise to design controls that turned a promising extract into a measurable, reproducible drug, and the administrative skill to assemble Best and Collip into a team that could finish what Banting alone could not. That is a genius of synthesis and stewardship rather than of the originating spark — closer to what a great orchestra conductor or an exacting editor contributes than to Banting's flash of an idea. The counter-case, made loudly and for decades by Banting himself, is that this kind of contribution is easily overstated by those who hold institutional power, and that Macleod's Nobel co-credit reflected seniority and eloquence as much as indispensable insight. Both things can be true at once, which is precisely why the historical fight over his reputation lasted sixty years.
Legacy
Insulin transformed type 1 diabetes from a near-certain death sentence into a manageable condition within a year of the Toronto team's breakthrough, and Macleod's name is now permanently fixed to that achievement through the shared 1923 Nobel Prize, a research auditorium at the University of Toronto, and Diabetes UK's award for long-term insulin survivors — even if it took nearly a century, and one meticulous historian, for the credit to catch up with the record.
Achievements
- Nobel Prize in Physiology or Medicine — 1923
- Affiliated with University of Toronto and Leipzig University
- Educated at University of Aberdeen
- Worked as physician, inventor and university teacher
